Caption Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-101,000
Closed -$2.14M 1209
2019
Q4
$2.14M Sell
101,000
-189,000
-65% -$3.33M 0.07% 342
2019
Q3
$3.85M Buy
290,000
+100,000
+53% +$1.47M 0.2% 140
2019
Q2
$2.63M Buy
190,000
+130,100
+217% +$1.96M 0.13% 205
2019
Q1
$1.15M Sell
59,900
-44,000
-42% -$709K 0.06% 329
2018
Q4
$1.48M Buy
+103,900
New +$2.06M 0.12% 217

Caption Management's IMMU Position: Q4 2020 in Review

Caption Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 31,100 shares — an estimated $2.65M sold.

Caption Management first reported a position in IMMU in Q2 2019 and held it in 4 quarters. The position peaked at $4.64M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Caption Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Caption Management sold 31,100 Immunomedics Inc shares in Q4 2020, an estimated $2.65M.
  • Caption Management first reported a position in Immunomedics Inc in Q2 2019 and held it in 4 quarters.
  • Caption Management's Immunomedics Inc position peaked at $4.64M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Caption Management's 13F filing for Q4 2020, filed 16 Feb 2021.